Results

Total Results: 1,292 records

Showing results for "how to do a case study".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
    September 01, 2014 - document are those of the authors, who are responsible for its contents; the findings and conclusions do … We chose to categorize this variable as a primary outcome instead of a harm. … In patients with CUR from non- obstructive causes, botulinum injections do not appear to reduce PVR urine … Chronic urinary retention in men: How we define it, and how does it affect treatment outcome. … They do not appear to provide strength of evidence for this conclusion.
  2. effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
    January 01, 2012 - and conclusions in this document are those of the authors, who are responsible for its content, and do … intervention. 16-22 Overall, experts stated that current OA therapies treat only the symptoms and do … intervention. 40-46 Overall, experts stated that current therapies for OA treat only the symptoms and do … In general, the experts thought that tofacitinib would not make a large shift in how RA is treated or … Experts all thought tofacitinib would have a large impact on costs, but diverged in how the impact
  3. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
    December 01, 2015 - According to a U.S. … According to a U.S. … to be well tolerated by patients who cannot tolerate IFN or do not want to use it. … to have high efficacy that is well tolerated by patients who cannot tolerate IFN or do not want to … large impact on how the disease is treated or diagnosed but that it would allow current treatment strategies
  4. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
    December 22, 2014 - According to a U.S. … Patients with HCV genotype 1b infection without cirrhosis do not require RBV. … to be well tolerated by patients who cannot tolerate IFN or do not want to use it. … to have high efficacy that is well tolerated by patients who cannot tolerate IFN or do not want to … large impact on how the disease is treated or diagnosed but 15 that it would allow current treatment
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-children_executive.pdf
    December 01, 2016 - improve mental health care and, if so, how? … po in ts N R S ub st an ce us e di so rd er s (a do le sc en ts w it h m ar ij … m et ab ol ic m on it or in g an d do cu m en ta ti on to ol ( M M T ) in th … more than just using an array of EBPs. 24 What continues to be unknown is how to bridge the gap … reviews of complex interventions: case study (CLUSTER).
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_executive.pdf
    May 01, 2013 - make decisions about when and how to treat patients with this condition. … 0– 2) – C hi ld re n (3 –1 2) – A do le sc en ts (1 3– 17 … Oral steroids do not offer any improvements in OME at 1 to 2 months after treatment (low strength of … Similarly, oral steroids with antibiotics do not provide improvements in OME at 1 to 2 months (moderate … Studies do not routinely document effect sizes and many researchers fail to report their statistical
  7. effectivehealthcare.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_june_2012.pdf
    January 01, 2012 - and conclusions in this document are those of the authors, who are responsible for its content, and do … In the ED, patient advocates identify patients who do not have a regular primary care provider in the … physicians with more timely data on how patients are taking their prescribed medications, so that … Thus, experts thought, this system might offer clinicians an objective means for determining how well … the specialists do not assume the care of patients, but instead guide the primary care provider in
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
    June 01, 2012 - and to combine diagnosis and treatment in a single procedure. … contrast agent-induced nephropathy, nephrogenic systemic fibrosis, anaphylaxis, arrhythmias—and how … body shape and limited functional capacity, women may not obtain the same test performance that men do … find studies that reported prognostic information on how the different NITs influenced clinical outcomes … The information from these clinical trials could inform how the choice of an NIT modality affects prognosis
  9. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - and conclusions in this document are those of the authors, who are responsible for its content, and do … device depends on how much it has been manipulated after collection. … (IND), investigational device exemption (IDE), or new biologic, depending on how FDA categorizes the … not responding to conservative therapy and who do not want to undergo knee replacement. … Unmet need and health outcomes: Current therapies for OA treat only the symptoms and do not restore
  10. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - It is still too early to determine how lorcaserin will diffuse among eligible patients with obesity … or to offer an option to patients who are obese and do not want to undergo bypass surgery but need … not provide coverage for antiobesity medications, and those that do, typically require that a patient … “The ability to prescribe a medication and do appropriate follow-up could provide clinician’s an opportunity … longer amount of time needed with each patient and a small disruption in how patients are currently
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
    August 01, 2021 - document are those of the authors, who are responsible for its contents; the findings and conclusions do … inform how ExaCT and similar tools may most reliably be used. … Seventy- five trials and eleven systematic reviews a day: how will we ever keep up? … Introduction—the why, what, when, and how. … How to conduct systematic reviews more expeditiously?
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/sickle-cell-dental-rapid-response.pdf
    July 01, 2024 - The search strategies used in PubMed and Embase are outlined in Appendix A (Tables A-1 to A-4). … States, the sole recommendation was that children with SCD should receive fluoride supplements if they do … strategies Date Database Name and URL Search Strategy(s)/Words Searched Including (if Applicable) How … 10 Date Database Name and URL Search Strategy(s)/Words Searched Including (if Applicable) How Items … 11 Date Database Name and URL Search Strategy(s)/Words Searched Including (if Applicable) How Items
  13. S123 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
    October 01, 2007 - patient groups, and researchers need to understand how these estimates relate to specific policy questions … to have this characteristic and X the factors within W that do not, Eqs. (1) and (2) can be rewritten … A 2-stage approach is used to estimate IV models. … and mastectomy for patients like those in the RCTs, but they differ across areas in how they extrapolate … In this study, we showed how inferences of treatment effectiveness can be made by applying risk adjustment
  14. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - nonsurgical option for patients who do not wish to undergo bariatric surgery. … Most third-party payers do not provide coverage for antiobesity medications, and those that do, typically … Several experts commented that patients would require initial training on how to properly self-inject … Other than initial training on how to use the injection pen, there is no reason to anticipate disruption … Lorcaserin’s availability after its approval was delayed for about 1 year as DEA evaluated how to schedule
  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
    December 01, 2011 - In patients with ACS who are undergoing PCI of native vessels, how do the rate and type of adverse events … A total of 165 articles were found to match our inclusion criteria. … In patients with ACS who are undergoing PCI of native vessels, how do the rate and type of adverse events … In addition, it is unclear how much experience the interventional cardiologists had in performing the … Reported as a percent ranging from 0 to 100 percent.
  16. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - for gastric bypass surgery or to offer an option to patients who are obese and do ES-5 not … A significant gap exists in obesity treatment care for patients who do not qualify for bariatric surgery … not provide coverage for antiobesity medications, and those that do, typically require that a patient … longer amounts of time needed for patients and a small disruption in how patients are currently managed … Lorcaserin’s availability after its approval was delayed for about 1 year as DEA evaluated how to schedule
  17. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
    September 26, 2014 - do not require insulin to survive. … Patients receive a treatment plan and are taught how to self-manage day-to-day care. … Experts generally agreed that this use of the surgery has high potential to disrupt how T2DM patients … the World Health Organization, people with diabetes who do not receive appropriate eye care have a … inform the sponsors of APDS IDE studies on how to support a PMA for “single patient use in the home
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
    October 06, 2006 - Then, a thorough search of abstracts and titles were reviewed to identify possible pertinent articles … that met inclusion criteria for applicable registers (N=106), a list of which were sent to Stanford … Not RCT Williams DO, Baim DS, Bates E, et al. … Level 2 review) οYes – This article is known to be a secondary report of a known trial that has already … If so, how?
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-testing-machine-learning-tool-chronic-pain.pdf
    November 01, 2020 - document are those of the authors, who are responsible for its contents; the findings and conclusions doA challenge to conducting living systematic reviews is identifying new articles in a timely manner. … 0.60 percent and a number needed to read (NNR) of 160 to 255, compared with precision of 0.61 to 1.44 … determine how missed studies could have impacted the conclusions of the LSR. … Introduction-the why, what, when, and how.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
    September 11, 2015 - and Nutrition Examination Survey found that 45 percent of adults with diabetes in the United States do … Review Health providers working in outpatient and primary care settings in the community struggle with how … For patients with T1DM, do behavioral programs implemented in the community health setting differ in … Do the factors that contribute to program effectiveness for patients with T2DM vary across the following … What contributions do languages other than English make on the results of meta-analyses?

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: